Page last updated: 2024-08-24

esmolol and tecadenoson

esmolol has been researched along with tecadenoson in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corino, VD; Holmqvist, F; Mainardi, LT; Platonov, PG1
Corino, VD; Mainardi, LT; Platonov, PG; Sandberg, F; Sörnmo, L1

Trials

2 trial(s) available for esmolol and tecadenoson

ArticleYear
Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:4

    Topics: Adenosine; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Furans; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists; Time Factors; Treatment Outcome

2014
Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2015, Volume: 20, Issue:6

    Topics: Adenosine; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Female; Furans; Humans; Male; Middle Aged; Propanolamines; Purinergic P1 Receptor Agonists

2015